Wed, January 28, 2009
Tue, January 27, 2009
[ Tue, Jan 27th 2009 ] - Market Wire
SCOR: SCOR sets up Zurich Hub
Mon, January 26, 2009
Sun, January 25, 2009
Fri, January 23, 2009
Thu, January 22, 2009
Wed, January 21, 2009
Tue, January 20, 2009
Mon, January 19, 2009
Fri, January 16, 2009
Thu, January 15, 2009
Wed, January 14, 2009
Tue, January 13, 2009
Mon, January 12, 2009

SurModics to Webcast Annual Meeting February 2


//health-fitness.news-articles.net/content/2009/ .. modics-to-webcast-annual-meeting-february-2.html
Published in Health and Fitness on Tuesday, January 20th 2009 at 13:08 GMT, Last Modified on 2009-01-20 13:09:18 by Market Wire   Print publication without navigation


EDEN PRAIRIE, Minn.--([ BUSINESS WIRE ])--SurModics, Inc. (Nasdaq: SRDX), a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Monday, February 2, at 4:00 p.m. CT.

Bruce Barclay, president and chief executive officer, Phil Ankeny, senior vice president and chief financial officer, and Ken Melrose, chairman of the board, will discuss financial results and achievements for the fiscal year ended September 30, 2008 as well as results from the first quarter of fiscal year 2009, and speak about the Company's strategy and prospects.

To access the webcast, go to the investor relations portion of the Company's website at [ www.surmodics.com ], on the day of the Annual Meeting and click on the webcast icon. In addition, the Annual Meeting audio and slide presentation will be archived on the Company's website following the meeting.

About SurModics, Inc.

SurModics, Inc. is a leading provider of drug delivery and surface modification technologies to the healthcare industry. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved patient outcomes. Core offerings include: drug delivery technologies (coatings, microparticles, nanoparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. SurModics is headquartered in Eden Prairie, Minnesota and its Brookwood Pharmaceuticals subsidiary is located in Birmingham, Alabama. For more information about the Company, visit [ www.surmodics.com ]. The content of SurModics' website is not part of this release or part of any filings the Company makes with the SEC.


Publication Contributing Sources